The 30 references in paper Z. Aysanov R., A. Chernyak V., E. Kalmanova N., З. Айсанов Р., А. Черняк В., Е. Калманова Н. (2015) “Спирометрия в диагностике и оценке терапии хронической обструктивной болезни легких в общеврачебной практике // Spirometry for diagnosis and therapeutic efficacy evaluation in chronic obstructive pulmonary disease in primary care” / spz:neicon:pulmonology:y:2014:i:5:p:101-110

1
Murray C.J.L., Lopez A. D. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study.Lancet. 1997; 349 (9064): 1498–1504.
(check this in PDF content)
2
Global initiative for chronic obstructive lung disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO work-shop report. Last updated 2011. www.gold copd.org
(check this in PDF content)
3
Hardie J.A., Buist A.S., Vollmer W.M. et al. Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers. Eur. Respir. J. 2002; 20 (5): 1117–1122.
(check this in PDF content)
4
Hwang Y.I., Kim C.H., Kang H.R.et al. Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria. J. Korean Med. Sci. 2009; 24 (4): 621–626.
(check this in PDF content)
5
Aggarwal A.N., Gupta D., Agarwal R., Jindal S.K. Comparison of the lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practice.Respir. Care. 2011; 56: 1778–1784.
(check this in PDF content)
6
Calverley P.M., Burge P.S., Spencer S. et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003; 58: 659–664.
(check this in PDF content)
7
Черняк А.В., Авдеев С.Н., Пашкова Т.Л., Айсанов З.Р. Бронходилатационный тест у больных с хронической обструктивной болезнью легких. Пульмонология. 2003; 1: 51–56.
(check this in PDF content)
8
O'Donnell D.E., Lam M., Webb K.A. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 542–549.
(check this in PDF content)
9
Casanova C., Cote C., de Torres J.P. et al. Inspiratory-tototal lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 171: 591–597.
(check this in PDF content)
10
Hill K., Goldstein R.S., Guyatt G.H. et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. Can. Med. Ass. J. 2010; 182 (7): 673–678.
(check this in PDF content)
11
Walters J. A., Haydn Walters E., Nelson M. et al. Factors associated with misdiagnosis of COPD in primary care. Prim. Care Respir. J. 2011; 20 (4): 396–402.
(check this in PDF content)
12
Bourbeau J., Sebaldt R.J., Day A. et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: The CAGE Study.Can. Respir. J. 2008; 15 (1):
(check this in PDF content)
13
19. 13. Siafakas N.M., Vermeire P., Pride N.B. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur. Res. J. 1995, 8 (8): 1398–1420.
(check this in PDF content)
14
Burdon J.G.W., Pain M.C.F., Rubinfeld A.R., Nana A. Chronic lung disease and the perception of breathlessness: a clinical perspective.Eur. Respir. J. 1994; 7 (7): 1342–1349.
(check this in PDF content)
15
Boom G., van Schayck C. P., Rutten-van Molken M. P. M. H. et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population: results and economic consequences of the DIMCA program. Am. J. Respir. Crit. Care Med. 1998; 158 (6): 1730–1738.
(check this in PDF content)
16
Sutherland E.R., Cherniack R.M. Management of chronic obstructive pulmonary disease.N. Engl. J. Med. 2004; 350: 2689–2697.
(check this in PDF content)
17
Holleman D.R. Jr, Simel D.L. Does the clinical examination predict airflow limitation? J. Am. Med. Ass. 1995; 273 (4): 313–319.
(check this in PDF content)
18
Melbye H., Aaraas I., Hana J., Hensrud A. Improving pulmonary auscultation as a tool in the diagnosis of bronchial obstruction – results of an educational intervention.Scan. J. Prim. Hlth Care. 1998; 16 (3): 160–164.
(check this in PDF content)
19
Kaplan A. Systems for the management of respiratory disease in primary care – an international series: Canada. Prim. Care Respir. J. 2008; 17 (2): 73–78.
(check this in PDF content)
20
Glasgow N. Systems for the management of respiratory disease in primary care – an international series: Australia. Prim. Care Respir. J. 2008; 17 (1): 19–25.
(check this in PDF content)
21
Aisanov Z., Lai C., Bauerle O. et al. Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world. Inter. J. COPD. 2012; 7: 1–12.
(check this in PDF content)
22
Saad N., Sedeno M., Metz K., Bourbeau J. Early COPD Diagnosis in Family Medicine Practice: How to Implement Spirometry?Inter. J. Fam. Med. 2014; 2014: 1–6.
(check this in PDF content)
23
Schermer T.R.J., Verweij E.H.A., Cretier R. et al. Accuracy and precision of desktop spirometers in general practices. Respiration. 2012; 83 (4): 344–352.
(check this in PDF content)
24
Schermer T.R.J., Crockett A.J., Poels P.J.P. et al. Quality of routine spirometry tests in Dutch general practices. Br. J. Gen. Pract. 2009; 59 (569): e376–e382.
(check this in PDF content)
25
Jones R.C.M., Dickson-Spillmann M., Mather M.J.C. et al. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit.Respir. Res. 2008; 9: art. 62.
(check this in PDF content)
26
Chavez P.C., Shokar N.K. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. J. COPD. 2009; 6 (6): 446–451.
(check this in PDF content)
27
Agusti A., Edwards L.D., Celli B. et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort.Eur. Respir. J. 2013; 42: 636–646.
(check this in PDF content)
28
Szafranski W., Cukier A, Ramirez A. et al. Efficacy and safety of budesonide / formoterol in the management of chronic obstructive pulmonary disease.Eur. Respir. J. 2003; 21: 74–81. Рис. 9. БУД / ФОРМ + ТИО: влияние на число обострений и госпитализаций (обострения / пациенты / 3 мес.) (адаптировано из [30])
(check this in PDF content)
29
Calverley P.M., Boonsawat W., Cseke Z. et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease.Eur. Respir. J. 2003; 22: 912–919.
(check this in PDF content)
30
Welte T., Miravitlles M., Hernandez P. et al. Efficacy and tolerability of budesonide / formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.Am. J. Respir. Crit. Care Med. 2009; 180: 741–750. Поступила 26.11.14
(check this in PDF content)